The Evaluation of an Interface for the Treatment of Obstructive Sleep Apnea (OSA)

The Evaluation of an Interface for the Treatment of Obstructive Sleep Apnea (OSA)

This investigation is designed to evaluate the performance as well as the patients overall acceptance of the interface.

A minimum of 40 OSA participants who currently use CPAP will be recruited for the trial. Participant will be in the trial for three weeks- first week will be a collection of Positive Airway Pressure baseline data on participant's usual interface. The participant will then use the trial interface in-home for 2 weeks. There is also an option of a six month extension if the participant wish to continue on the trial interface.

Inclusion Criteria:

• Adult (18+ years of age)
• Able to give written consent
• AHI ≥ 5 on diagnostic night
• Either prescribed APAP, CPAP or Bi-level PAP for OSA

Exclusion Criteria:

• Inability to give written consent
• Anatomical or physiological conditions making PAP therapy inappropriate
• Commercial drivers who are investigated by New Zealand Transport Agency (NZTA)
• Current diagnosis of respiratory disease or CO2 retention
• Pregnant or may think they are pregnant.